Percutaneous closure of perimembranous ventricular septal defects (VSDs) has been
feasible, safe, and effective with the new Amplatzer membranous septal occluder. We report …

Background: This study reports our experience in the nonsurgical closure of
perimembranous ventricular septal defects in children and adolescents with the Amplatzer …

Objective: To report the immediate and midterm results of transcatheter closure of
perimembranous ventricular septal defect (PmVSD) using the Amplatzer membranous VSD …

Using an Amplatzer membranous eccentric occluder, 186 patients with an average weight of
43.5 kg (range 12.5–77) underwent attempted catheter closure of a perimembranous …

Transcatheter closure of perimembranous ventricular septal defects with coils or devices
designed to close other lesions may be complicated by embolization or aortic insufficiency …

The surgical closure of membranous ventricular septal defects (VSDs) is associated with
morbidity and low mortality. Six patients with VSDs located in the membranous part of the …

OBJECTIVE: The development of the Amplatzer Membranous VSD Occluder (AGA Medical
Corp, Plymouth, Minn) for closure of the perimembranous ventricular septal defect has …

Objectives. To demonstrate safety and efficacy of using different generations of softer
Amplatzer™ devices for ventricular septal defect (VSD) closure to avoid serious …

Objective To show that transcatheter closure of perimembranous ventricular septal defect
(PMVSD) with the Amplatzer ductal occluder (ADO, AGA Medical Corp, Plymouth …

Background: Transcatheter closure of a perimembranous ventricular septal defect (PmVSD)
is usually performed with an asymmetric Amplatzer occluder, which is not an ideal device …